Notice of Open Public Hearing, 34254 [2019-15245]

Download as PDF 34254 Federal Register / Vol. 84, No. 137 / Wednesday, July 17, 2019 / Notices Issued on: July 10, 2019. Linda M. Gehrke, Regional Administrator. the relevant sanctions authority listed below. Entity [FR Doc. 2019–15156 Filed 7–16–19; 8:45 am] 1. GENERAL DIRECTORATE OF MILITARY COUNTERINTELLIGENCE (a.k.a. DGCIM; a.k.a. DIRECCION GENERAL DE CONTRAINTELIGENCIA MILITAR (Latin: ´ N GENERAL DE DIRECCIO CONTRAINTELIGENCIA MILITAR)), Caracas, Capital District, Venezuela [VENEZUELA–EO13850]. BILLING CODE P DEPARTMENT OF THE TREASURY Office of Foreign Assets Control Notice of OFAC Sanctions Action Office of Foreign Assets Control, Treasury. ACTION: Notice. AGENCY: The Department of the Treasury’s Office of Foreign Assets Control (OFAC) is publishing the names of one or more persons that have been placed on OFAC’s Specially Designated Nationals and Blocked Persons List based on OFAC’s determination that one or more applicable legal criteria were satisfied. All property and interests in property subject to U.S. jurisdiction of this person are blocked, and U.S. persons are generally prohibited from engaging in transactions with them. DATES: See SUPPLEMENTARY INFORMATION section. FOR FURTHER INFORMATION CONTACT: OFAC: Associate Director for Global Targeting, tel.: 202–622–2420; Assistant Director for Sanctions Compliance & Evaluation, tel.: 202–622–2490; Assistant Director for Licensing, tel.: 202–622–2480; Assistant Director for Regulatory Affairs, tel.: 202–622–4855; or the Department of the Treasury’s Office of the General Counsel: Office of the Chief Counsel (Foreign Assets Control), tel.: 202–622–2410. SUPPLEMENTARY INFORMATION: SUMMARY: Electronic Availability The Specially Designated Nationals and Blocked Persons List and additional information concerning OFAC sanctions programs are available on OFAC’s website (https://www.treasury.gov/ofac). Notice of OFAC Action jbell on DSK3GLQ082PROD with NOTICES On July 11, 2019, OFAC determined that the property and interests in property subject to U.S. jurisdiction of the following person are blocked under VerDate Sep<11>2014 18:05 Jul 16, 2019 Jkt 247001 Designated pursuant to section 1(a)(i) of Executive Order 13850 (E.O. 13850) of November 1, 2018, ‘‘Blocking Property of Additional Persons Contributing to the Situation in Venezuela,’’ as amended by Executive Order 13857, ‘‘Taking Additional Steps to Address the National Emergency with Respect to Venezuela,’’ of January 25, 2019, for operating in the defense and security sector of the Venezuelan economy. Dated: July 11, 2019. Andrea Gacki, Director, Office of Foreign Assets Control. [FR Doc. 2019–15207 Filed 7–16–19; 8:45 am] BILLING CODE 4810–AL–P U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION Notice of Open Public Hearing U.S.-China Economic and Security Review Commission. ACTION: Notice of open public hearing. AGENCY: Notice is hereby given of the following hearing of the U.S.-China Economic and Security Review Commission. The Commission is mandated by Congress to investigate, assess, and report to Congress annually on ‘‘the national security implications of the economic relationship between the United States and the People’s Republic of China.’’ Pursuant to this mandate, the Commission will hold a public hearing in Washington, DC on July 31, 2019 on ‘‘Exploring the Growing U.S. Reliance on China’s Biotech and Pharmaceutical Products.’’ DATES: The hearing is scheduled for Wednesday, July 31, 2019 at 9:00 a.m. SUMMARY: PO 00000 Frm 00139 Fmt 4703 Sfmt 9990 428A Russell Senate Office Building, Washington, DC. A detailed agenda for the hearing will be posted on the Commission’s website at www.uscc.gov. Also, please check the Commission’s website for possible changes to the hearing schedule. Reservations are not required to attend the hearing. ADDRESSES: Any member of the public seeking further information concerning the hearing should contact Leslie Tisdale Reagan, 444 North Capitol Street NW, Suite 602, Washington, DC 20001; telephone: 202– 624–1496, or via email at lreagan@ uscc.gov. Reservations are not required to attend the hearing. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: Background: This is the seventh public hearing the Commission will hold during its 2019 report cycle. The hearing will assess China’s role in global health industries and implications for U.S. health, biotech, pharmaceutical firms, and the U.S. public. The hearing will also examine the activities of Chinese health and biotech firms in the United States and the ability of U.S. health and biotech firms to access the China market. The hearing will be cochaired by Senator James Talent and Commissioner Michael Wessel. Any interested party may file a written statement by July 31, 2019 by mailing to the contact above. A portion of each panel will include a question and answer period between the Commissioners and the witnesses. Authority: Congress created the U.S.China Economic and Security Review Commission in 2000 in the National Defense Authorization Act (Pub. L. 106– 398), as amended by Division P of the Consolidated Appropriations Resolution, 2003 (Pub. L. 108–7), as amended by Public Law 109–108 (November 22, 2005), as amended by Public Law 113–291 (December 19, 2014). Dated: July 12, 2019. Daniel W. Peck, Executive Director, U.S.-China Economic and Security Review Commission. [FR Doc. 2019–15245 Filed 7–16–19; 8:45 am] BILLING CODE 1137–00–P E:\FR\FM\17JYN1.SGM 17JYN1

Agencies

[Federal Register Volume 84, Number 137 (Wednesday, July 17, 2019)]
[Notices]
[Page 34254]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15245]


=======================================================================
-----------------------------------------------------------------------

U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION


Notice of Open Public Hearing

AGENCY: U.S.-China Economic and Security Review Commission.

ACTION: Notice of open public hearing.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given of the following hearing of the U.S.-
China Economic and Security Review Commission.
    The Commission is mandated by Congress to investigate, assess, and 
report to Congress annually on ``the national security implications of 
the economic relationship between the United States and the People's 
Republic of China.'' Pursuant to this mandate, the Commission will hold 
a public hearing in Washington, DC on July 31, 2019 on ``Exploring the 
Growing U.S. Reliance on China's Biotech and Pharmaceutical Products.''

DATES: The hearing is scheduled for Wednesday, July 31, 2019 at 9:00 
a.m.

ADDRESSES: 428A Russell Senate Office Building, Washington, DC. A 
detailed agenda for the hearing will be posted on the Commission's 
website at www.uscc.gov. Also, please check the Commission's website 
for possible changes to the hearing schedule. Reservations are not 
required to attend the hearing.

FOR FURTHER INFORMATION CONTACT: Any member of the public seeking 
further information concerning the hearing should contact Leslie 
Tisdale Reagan, 444 North Capitol Street NW, Suite 602, Washington, DC 
20001; telephone: 202-624-1496, or via email at [email protected]. 
Reservations are not required to attend the hearing.

SUPPLEMENTARY INFORMATION:
    Background: This is the seventh public hearing the Commission will 
hold during its 2019 report cycle. The hearing will assess China's role 
in global health industries and implications for U.S. health, biotech, 
pharmaceutical firms, and the U.S. public. The hearing will also 
examine the activities of Chinese health and biotech firms in the 
United States and the ability of U.S. health and biotech firms to 
access the China market. The hearing will be co-chaired by Senator 
James Talent and Commissioner Michael Wessel. Any interested party may 
file a written statement by July 31, 2019 by mailing to the contact 
above. A portion of each panel will include a question and answer 
period between the Commissioners and the witnesses.
    Authority: Congress created the U.S.-China Economic and Security 
Review Commission in 2000 in the National Defense Authorization Act 
(Pub. L. 106-398), as amended by Division P of the Consolidated 
Appropriations Resolution, 2003 (Pub. L. 108-7), as amended by Public 
Law 109-108 (November 22, 2005), as amended by Public Law 113-291 
(December 19, 2014).

    Dated: July 12, 2019.
Daniel W. Peck,
Executive Director, U.S.-China Economic and Security Review Commission.
[FR Doc. 2019-15245 Filed 7-16-19; 8:45 am]
 BILLING CODE 1137-00-P